Prokarium Ltd   Report issue

For profit Phase 1
Founded: London United Kingdom (2007)

Organization Overview

First Clinical Trial
2019
NCT04349553
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Prokarium Ltd